Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Satraplatin and Erlotinib in Elderly NSCLC
NCT00370383Phase 2Completed
- Sponsor
- Agennix AG
- Start
- Jul 2006
- Primary completion
- Feb 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 3
01
Overview
A Phase 2 trial of satraplatin in non-small cell lung cancer (NSCLC), sponsored by Agennix AG. Started Jul 2006; status: completed.
02
Drugs
satraplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00370383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00370383.